New Pill Approved for Schizophrenia, Bipolar Disorder

(MedPage Today) — The FDA has approved milsaperidone tablets (Bysanti) as a first-line treatment for adults with schizophrenia and manic or mixed episodes related to bipolar I disorder, Vanda Pharmaceuticals announced Friday. Milsaperidone is an active…